论文部分内容阅读
目的：观察生物反馈技术对临床治疗效果的影响。方法：将冠心病心绞痛患者60例随机分成两组，第1组服用复方丹参滴丸10#tid，疗程5周；第2组服用药物方法相同，还同时加用生物反馈治疗，每日一次30分钟，10次后隔日一次至疗程结束。结果：两组患者的临床症状、ECG表现、全血粘度和SOD都有显著改善，且以第2组改善明显。此外，生活质量（QOL）评定，包括日常生活能力、KPS心功能计分、心理量表评分（SCL－90）及心血管疾病专用QOL量表的评定亦以第2组改善显著。结论：生物反馈技术可增加复方丹参滴丸的临床疗效。
Objective: To observe the effect of biofeedback technology on clinical therapeutic effect. Methods: 60 patients with coronary heart disease and angina pectoris were randomly divided into two groups. The first group took Compound Danshen Dripping Pills 10#tid for 5 weeks; the second group used the same drugs, but also added biofeedback treatment, once a day 30 Minutes, once every 10 days until end of treatment. RESULTS: Clinical symptoms, ECG performance, whole blood viscosity, and SOD were significantly improved in both groups, and were significantly improved in the second group. In addition, quality of life (QOL) assessment, including the assessment of daily living ability, KPS cardiac function score, psychological scale score (SCL-90), and the exclusive QOL scale for cardiovascular disease were also significantly improved in the second group. Conclusion: Biofeedback technology can increase the clinical efficacy of Compound Danshen Dripping Pills.